Overview

Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment
Details
Lead Sponsor:
Bayer
Treatments:
Angiotensin-Converting Enzyme Inhibitors
Telmisartan